VALLON PHARMACEU(VLON) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 GRI BIO, INC. (Exact name of registrant as specified in its charter) | Delaware | 001-40034 | 82-4369909 | | --- | --- | --- | | (State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | | of incorporation) | | | (619) 400-1170 (Registrant's te ...